Breast neoplasms male. Medical search

Tumors or cancer of the human BREAST.

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.

Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.

An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Pathological processes of the BREAST.

The nursing of an infant at the breast.

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.

Radiographic examination of the breast.

Neoplasms containing cyst-like formations or producing mucin or serum.

A cell line derived from cultured tumor cells.

A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.

Ability of neoplasms to infiltrate and actively destroy surrounding tissue.

Histochemical localization of immunoreactive substances using labeled antibodies as reagents.

Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.

A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.

Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.

Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.

Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.

Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.

The inspection of one's breasts, usually for signs of disease, especially neoplastic disease.

Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.

The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Tumors or cancer of the SKIN.

A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.

One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

DNA present in neoplastic tissue.

A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)

Surgical procedure to remove one or both breasts.

An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)

Tumors or cancer of the LUNG.

Tumors or cancers of the KIDNEY.

A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1205)

An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.

The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.

Tumors or cancer located in bone tissue or specific BONES.

Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.

Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast.

Tumors or cancer of the THYROID GLAND.

Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.

A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)

Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.

Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Tumors or cancer of the LIVER.

Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.

The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.

An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed)

Tumors or cancer of the PAROTID GLAND.

Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.

A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)

Surgical reconstruction of the breast including both augmentation and reduction.

Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.

Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.

A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.

Tumors or cancer of the APPENDIX.

A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.

The conic organs which usually give outlet to milk from the mammary glands.

Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.

Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.

Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.

All of the processes involved in increasing CELL NUMBER including CELL DIVISION.

One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.

A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.

Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.

Tumors or cancer of the ENDOCRINE GLANDS.

An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)

Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.

A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.

The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.

The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.

Elements of limited time intervals, contributing to particular results or situations.

A malignant epithelial tumor with a glandular organization.

Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.

Tumors or cancer of the SALIVARY GLANDS.

Tumors or cancer of the EYE.

Tumors or cancer of the UTERUS.

Experimental transplantation of neoplasms in laboratory animals for research purposes.

Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.

The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.

Surgical insertion of an inert sac filled with silicone or other material to augment the female form cosmetically.

Tumors or cancer of the NOSE.

Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.

A large, nuclear protein, encoded by the BRCA2 gene (GENE, BRCA2). Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev. 2000;14(11):1400-6)

Tumors or cancer of the COLON.

An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.

Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

The phosphoprotein encoded by the BRCA1 gene (GENE, BRCA1). In normal cells the BRCA1 protein is localized in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localized mainly in the cytoplasm. (Science 1995;270(5237):713,789-91)

RNA present in neoplastic tissue.

Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.

Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.

Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.

Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.

A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.

Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.

Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)

Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.

A benign epithelial tumor with a glandular organization.

Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.

The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.

A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6)

RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.

A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)

A general term for various neoplastic diseases of the lymphoid tissue.

Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.

Tumors or cancer of the INTESTINES.

Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.

Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.

A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.

The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.

Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.

The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.

Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.

Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.

The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (RECEPTOR, ERBB-2), a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog (v-erbB) which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.

Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.

Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.

The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.

Neoplasms composed of more than one type of neoplastic tissue.

Organized periodic procedures performed on large groups of people for the purpose of detecting disease.

Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.

Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.

The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)

Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.

A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.

The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.

A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)

Tumors or cancer of the MANDIBLE.

A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)

Tumors or cancer of the THYMUS GLAND.

Tumors or cancer of the SPLEEN.

Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Tumors or cancer of the BILE DUCTS.

Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.

A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)

Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.

They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.

One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.

Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.

The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.

Cancer or tumors of the MAXILLA or upper jaw.

Tomography using x-ray transmission and a computer algorithm to reconstruct the image.

In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.

Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.

A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Tumors or cancer of the anal gland.

In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.

Antibodies produced by a single clone of cells.

Tumors or cancer of the STOMACH.

Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.

Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.

Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not.

A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.

The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.

A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.

Tumors or cancer of the DUODENUM.

Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.

Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.

An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Tumors or cancer of the MOUTH.

Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.

Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING.

A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.

Tumors or cancers of the ADRENAL CORTEX.

Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.

Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.

Tumors or cancer of the MEDIASTINUM.

Tumors or cancer of the URINARY BLADDER.

Transplantation between animals of different species.

Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)

A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)

A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS.

Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale.

Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. (1/361)

Inherited susceptibility to breast cancer is associated with an early onset and bilateral disease. The extent of familial risks has not, however, been fully assessed in population-based incidence studies. The purpose of the study was to quantify the risks for cancers of the breast, ovary and other sites of close relatives of women in whom breast cancer was diagnosed at an early age. Records collected between 1943 and 1990 at the Danish Cancer Registry were searched, and 2860 women were found in whom breast cancer was diagnosed before age 40. Population registers and parish records were used to identify 14 973 parents, siblings and offspring of these women. Cancer occurrence through to 31 December 1993 was determined within the Cancer Registry's files and compared with national incidence rates. Women with early-onset breast cancer were at a nearly fourfold increased risk of developing a new cancer later in life (268 observed vs. 68.9 expected). The excess risk was most evident for second cancer of the breast (181 vs. 24.5) and for ovarian cancer (20 vs. 3.3). For mothers and sisters, risks for cancers of the breast and ovary were significantly increased by two- to threefold. Bilateral breast cancer and breast-ovarian cancer were very strong predictors of familial risks, with one in four female relatives predicted to develop breast and/or ovarian cancer by age 75. Mothers had a slightly increased risk of colon cancer, but not endometrial cancer. The risk for breast cancer was also increased among fathers (standardized incidence ratio 2.5; 95% CI 0.5-7.4) and especially brothers (29; 7.7-74), although based on small numbers. The risk for prostatic cancer was unremarkable. In this large population-based survey, the first-degree relatives of women who developed breast cancer before age 40 were prone to ovarian cancer as well as male and female breast cancer, but not other tumours that may share susceptibility genes with breast cancer. (+info)

Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. (2/361)

Androgen receptor (AR) expression was retrospectively analysed in 47 primary male breast carcinomas (MBCs) using a monoclonal antibody on formalin-fixed, paraffin-embedded tissues. AR immunopositivity was detected in 16 out of 47 (34%) cases. No association was found with patient age, tumour stage, progesterone receptor (PGR) or p53 protein expression. Well-differentiated MBCs tended to be AR positive more often than poorly differentiated ones (P = 0.08). A negative association was found between ARs and cell proliferative activity: MIB-1 scores were higher (25.4%) in AR-negative than in AR-positive cases (21.11%; P = 0.04). A strong positive association (P = 0.0001) was found between ARs and oestrogen receptors (ERs). In univariate analysis, ARs (as well as ERs and PGRs) were not correlated with overall survival; tumour histological grade (P = 0.02), size (P = 0.01), p53 expression (P = 0.0008) and MIB-1 scores (P = 0.0003) had strong prognostic value. In multivariate survival analysis, only p53 expression (P = 0.002) and histological grade (P = 0.02) retained independent prognostic significance. In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC. (+info)

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. (3/361)

To determine the contribution of BRCA1 and BRCA2 mutations to the pathogenesis of male breast cancer in Hungary, the country with the highest male breast cancer mortality rates in continental Europe, a series of 18 male breast cancer patients and three patients with gynecomastia was analyzed for germ-line mutations in both BRCA1 and BRCA2. Although no germ-line BRCA1 mutation was observed, 6 of the 18 male breast cancer cases (33%) carried truncating mutations in the BRCA2 gene. Unexpectedly, none of them reported a family history for breast/ovarian cancer. Four of six truncating mutations were novel, and two mutations were recurrent. Four patients (22%) had a family history of breast/ovarian cancer in at least one first- or second-degree relative; however, no BRCA2 mutation was identified among them. No mutation was identified in either of the genes in the gynecomastias. These results provide evidence for a strong genetic component of male breast cancer in Hungary. (+info)

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. (4/361)

Epidemiological studies in ataxia telangiectasia (AT) families have suggested that AT heterozygotes could have an increased cancer risk, especially breast cancer (BC) in women. It has also been suggested that an increased sensibility of AT heterozygotes to the effect of ionizing radiation could be responsible for the increased BC risk. BC relative risk (RR) estimation in AT heterozygotes within families ascertained through AT children is presented here. Family data collected included demographic characteristics, occurrence of cancers, past radiation exposures and blood samples. DNA samples were studied using seven ATM linked microsatellites markers allowing AT haplotypes reconstitution. The relative risk of BC was assessed using French estimated incidence rates. A significant increase risk of BC is found among obligate ATM heterozygotes with a point estimate of 3.32 (P = 0.002). BC relative risk calculated according to age is significantly increased among the obligate ATM heterozygotes female relatives with an age < or = 44 years (RR = 4.55, P = 0.005). The BC relative risk is statistically borderline among the obligate ATM heterozygote female relatives with an age > or = 45 years (RR = 2.48, P = 0.08). The estimated BC relative risk among ATM heterozygotes is consistent with previously published data. However, the increased risk is only a little higher than classical reproductive risk factors and similar to the risk associated with a first-degree relative affected by BC. (+info)

Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (5/361)

The purpose of this study was to determine the outcome of high-dose therapy with autologous hematopoietic stem cell support (autotransplants) in men with breast cancer. We studied 13 men receiving autotransplants for breast cancer and reported to the Autologous Blood and Marrow Transplant Registry (ABMTR) by 10 centers. Six men had stage 2 breast cancer, four had stage 3, and three had metastatic breast cancer. Of twelve tumors tested, all were estrogen receptor positive. Median age at transplant was 50 years. The most common conditioning regimen was cyclophosphamide, thiotepa and carboplatin (n = 5); the remaining eight men received other alkylator-based regimens. Three men received bone marrow, eight received blood stem cells, and two received both for hematopoietic support. All patients had hematopoietic recovery. There were no unexpected regimen-related toxicities. Of 10 men receiving autotransplants as adjuvant therapy, three relapsed 3, 5 and 50 months post-transplant and died 16, 19 and 67 months post-transplant. Seven of 10 are disease-free with median follow-up of 23 months (range 6-50 months). Of three men treated for metastatic breast cancer, one had progressive disease and two recurrent disease at 6, 7 and 16 months post-transplant. In conclusion, results of autotransplants for male breast cancer appear similar to those reported for women receiving autotransplants for breast cancer. (+info)

A polymorphism in the CYP17 gene is associated with male breast cancer. (6/361)

The CYP17 gene codes for the cytochrome P450c17alpha enzyme that is involved in the synthesis of oestrogens. This case-control study from the South East of Scotland shows that a polymorphism of the CYP17 gene is associated with an increased risk of male breast cancer. (+info)

A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. (7/361)

High-dose chemotherapy (HDCT) is currently under evaluation for high-risk primary breast cancer (HRPBC), defined by extensive axillary nodal involvement or inflammatory breast carcinoma. Phase II studies of HDCT for HRPBC show that 30-40% of patients eventually relapse. We retrospectively reviewed 176 patients enrolled in clinical trials of HDCT for HRPBC at the University of Colorado and analyzed 23 potential predictive variables for relapse. All of the patients received the same regimen, with cyclophosphamide, cisplatin, and BCNU. Nine patients who experienced a toxic death were excluded from this analysis. The resulting predictive model was subsequently tested in an independent patient set treated at Duke University with the same HDCT regimen. Nodal ratio (number of involved nodes:number of sampled nodes), tumor size, grade, stage, estrogen receptor, progesterone receptor, and clinical inflammatory breast carcinoma correlated with risk of relapse. Nodal ratio, tumor size, and the combined estrogen receptor/progesterone receptor status were independent predictors. A scoring system using those three variables determines the risk of relapse, with a sensitivity and specificity of 60 and 90%, respectively, and a positive and negative predictive value of 65 and 88%, respectively. The differences in relapse-free survival and overall survival between high- and low-score patients were highly significant (P<0.000001). This model was subsequently validated in the Duke patient set. This model can identify two subgroups of HRPBC patients with low (12%) and high (65%) risk for recurrence after HDCT. Future research that tests new therapies will focus on those patients with a high score. (+info)

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer. (8/361)

For genetic counselling of a woman on familial breast cancer, an accurate evaluation of the probability that she carries a germ-line mutation is needed to assist in making decisions about genetic-testing. We used data from eight collaborating centres comprising 618 families (346 breast cancer only, 239 breast or ovarian cancer) recruited as research families or counselled for familial breast cancer, representing a broad range of family structures. Screening was performed in affected women from 618 families for germ-line mutations in BRCA1 and in 176 families for BRCA2 mutations, using different methods including SSCP, CSGE, DGGE, FAMA and PTT analysis followed by direct sequencing. Germ-line BRCA1 mutations were detected in 132 families and BRCA2 mutations in 16 families. The probability of being a carrier of a dominant breast cancer gene was calculated for the screened individual under the established genetic model for breast cancer susceptibility, first, with parameters for age-specific penetrances for breast cancer only [7] and, second, with age-specific penetrances for ovarian cancer in addition [20]. Our results indicate that the estimated probability of carrying a dominant breast cancer gene gives a direct measure of the likelihood of detecting mutations in BRCA1 and BRCA2. For breast/ovarian cancer families, the genetic model according to Narod et al. [20] is preferable for calculating the proband's genetic risk, and gives detection rates that indicate a 50% sensitivity of the gene test. Due to the incomplete BRCA2 screening of the families, we cannot yet draw any conclusions with respect to the breast cancer only families. (+info)

Margolese RG, Fisher B, Hortobagyi GN, Bloomer WD (2000). "Neoplasms of the Breast". In Bast RC, Kufe DW, Pollock RE, et al. ( ... Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (July 2004). "Breast carcinoma in men: a population-based study". ... Mainly taken from risk factors for breast cancer, risk factors can be described in terms of, for example: Relative risk, such ... of breast cancer cases are diagnosed in women." Increase in incidence in the exposed group, such as "each daily alcoholic ...

https://en.wikipedia.org/wiki/Risk_factor

Fibromyoma of the breast is an extremely rare benign breast neoplasm. Most reports in literature mention a history of ... The symptoms for a 30 year old male with a 10 cm leiomyoma included "dead leg" pains. Tumor was intertwined with quadricep ... Mesenchymal neoplasms of the gallbladder are rare and in particular leiomyomas of the gallbladder have been rarely reported, ... ISBN 0-7216-2921-0. Radiologic Pathology Archives: Esophageal Neoplasms: Radiologic-Pathologic Correlation Rachel B. Lewis, ...

https://en.wikipedia.org/wiki/Leiomyoma

The male children of mothers who were, during pregnancy of those children, exposed to high levels of toxic dioxins due to the ... In 2009, an update including 5 more years (up to 1996) found an increase in "lymphatic and hematopoietic tissue neoplasms" and ... increased breast cancer. A 2008 study evaluated whether maternal exposure is associated with modified neonatal thyroid function ... This accident was ranked eighth in a list of the worst man-made environmental disasters by Time magazine in 2010. The Seveso ...

https://en.wikipedia.org/wiki/Seveso_disaster

... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... vaginal neoplasms MeSH C04.588.945.418.968 - vulvar neoplasms MeSH C04.588.945.440 - genital neoplasms, male MeSH C04.588. ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ... femoral neoplasms MeSH C04.588.149.721 - skull neoplasms MeSH C04.588.149.721.450 - jaw neoplasms MeSH C04.588.149.721.450.583 ...

https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C04)

... benign and metastatic neoplasms (such as breast cancer, pancreatic cancer, and oral cancer), infectious conditions (such as HIV ... "Validation of salivary testosterone as a screening test for male hypogonadism". Aging Male. 9 (3): 165-9. doi:10.1080/ ... A 2000 study compared the salivary levels of a breast cancer marker (HER2/neu) in healthy women, women with benign breast ... compared saliva from breast cancer patients to that from healthy individuals and observed, notably, that breast cancer patients ...

https://en.wikipedia.org/wiki/Saliva_testing

... breast cyst MeSH C17.800.090.500 - breast neoplasms MeSH C17.800.090.500.260 - breast neoplasms, male MeSH C17.800.090.500.390 ... sebaceous gland neoplasms MeSH C17.800.882.743 - sweat gland neoplasms MeSH C17.800.893.592 - leg ulcer MeSH C17.800.893.592. ... carcinoma, ductal, breast MeSH C17.800.090.500.762 - phyllodes tumor MeSH C17.800.090.750 - fibrocystic breast disease MeSH ... sebaceous gland neoplasms MeSH C17.800.804.066 - acrodermatitis MeSH C17.800.804.150 - dyskeratosis congenita MeSH C17.800. ...

https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C17)

The male children of mothers who were, during pregnancy of those children, exposed to high levels of toxic dioxins due to the ... In 2009, an update including 5 more years (up to 1996) found an increase in "lymphatic and hematopoietic tissue neoplasms" and ... increased breast cancer.[11]. ... "Out for the count: Why levels of sperm in men are falling". The ...

https://en.m.wikipedia.org/wiki/Seveso_disaster

... (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast ... Alcohol use disorder has been linked to male breast cancer. The highest risk for male breast cancer is carried by males with ... Male BRCA mutation carriers are thought to be at higher risk for breast cancer as well, with roughly 10% of male breast cancer ... male cancer diagnoses in a pathology review represented breast cancer. Incidence of male breast cancer has been increasing ...

https://en.wikipedia.org/wiki/Male_breast_cancer

This compares with 73% for affected males. The difference may be due to much smaller breast tissue in males and increased ... Li F.P.; Fraumeni J.F. (October 1969). "Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?". Ann. ... Erratum for "Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms"". Science. 259 ( ... 1990). "Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms". Science. 250 (4985): ...

https://en.wikipedia.org/wiki/Li–Fraumeni_syndrome

In 2006, life expectancy for males in Cyprus was 79 and for females 82 years. Infant mortality in 2002 was 5 per 1,000 live ... The two most common cancers are prostate cancer and breast cancer. The measles immunisation rate of 86% for one year olds is ... The three most common causes of death are circulatory disease, neoplasms, and respiratory disease. ... As of 2013, life expectancy for females was 85 and for males 80. Infant mortality in 2002 was 5 per 1,000 live births, ...

https://en.wikipedia.org/wiki/Health_in_Cyprus

A urogenital neoplasm is a tumor of the urogenital system. Types include: Cancer of the breast and female genital organs: ( ... Cancer of the male genital organs (Carcinoma of the penis, Prostate cancer, Testicular cancer) Cancer of the urinary organs ( ... Breast cancer, Vulvar cancer, Vaginal cancer, Vaginal tumors, Cervical cancer, Uterine cancer, Endometrial cancer, Ovarian ...

https://en.wikipedia.org/wiki/Urogenital_neoplasm

... even in the absence of a breast-cancer gene.[69] Similarly, men of African ancestry have significantly higher levels of ... They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often ... For example, the most common type of breast cancer is called ductal carcinoma of the breast. Here, the adjective ductal refers ... Radiation to the breast reduces the ability of that breast to produce milk and increases the risk of mastitis. Also, when ...

https://en.wikipedia.org/wiki/Malignant_neoplasms

... of skin 173 Other malignant neoplasm of skin 174 Malignant neoplasm of female breast 175 Malignant neoplasm of male breast 176 ... neoplasm of uterus 220 Benign neoplasm of ovary 221 Benign neoplasm of other female genital organs 222 Benign neoplasm of male ... 140 Malignant neoplasm of lip 141 Malignant neoplasm of tongue 142 Malignant neoplasm of major salivary glands 143 Malignant ... benign neoplasm of connective and other soft tissue 216 Benign neoplasm of skin Melanocytic nevus 217 Benign neoplasm of breast ...

https://en.wikipedia.org/wiki/List_of_ICD-9_codes_140–239:_neoplasms

... astrocytic neoplasms, phaeochromocytomas and breast cancer. No effective therapy NF1 yet exists. Instead, people with ... Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion. Twenty six tests were ... The remaining tests were carried out on heterozygous mutant adult mice: females displayed abnormal hair cycling while males had ... which develops myeloproliferative neoplasms similar to those found in NF1 juvenile myelomonocytic leukemia/JMML) were used to ...

https://en.wikipedia.org/wiki/Neurofibromin_1

The incidence of mammary desmoid tumors is less than 0.2% of primary breast neoplasms. In Gardner's syndrome, the incidence ... Each of their children, male and female alike, are at 50% risk of inheriting the gene for Gardner syndrome. Gardner syndrome ... The extra-abdominal form is rare and desmoids of the breast may arise in the mammary gland or may occur as an extension of a ... Rammohan A, Wood JJ (2012). "Desmoid tumour of the breast as a manifestation of Gardner's syndrome". Int J Surg Case Rep. 3 (5 ...

https://en.wikipedia.org/wiki/Gardner's_syndrome

... breast cancer, papillary thyroid carcinoma, non-small cell lung cancer, glioma, gastric cancer, thyroid neoplasms, and rectal ... Although BTHS occurs almost exclusively in males, there has been one identified case of BTHS in a female patient. Tafazzin is ... including breast cancer, papillary thyroid carcinoma and non-small cell lung cancer, glioma, gastric cancer, thyroid neoplasms ... In thyroid neoplasm, TAZ allows follicular adenomas to be distinguished from follicular carcinomas, while in cervical cancer ...

https://en.wikipedia.org/wiki/Tafazzin

... with females affected much more commonly than males. Nearly all of the cases reported so far have a benign behavior (no ... the findings are quite similar to fibrocystic changes of the breast, although they are different enough, that it is now ... recognized to actually represent a true neoplasm (clonal proliferation) through various studies. Specifically, the lesions are ...

https://en.wikipedia.org/wiki/Sclerosing_polycystic_adenosis

The neoplasm occurs in individuals of all ages but predominates in the elderly; in children, it afflicts males and females ... and clinical evidence of malignant pDC infiltrations in the breasts, eyes, kidneys, lungs, gastrointestinal tract, bone, ... equally but in adults is far more common (~75% of cases) in males. Blastic plasmacytoid dendritic cell neoplasm typically ... Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy. It was initially regarded as a form of ...

https://en.wikipedia.org/wiki/Blastic_plasmacytoid_dendritic_cell_neoplasm

... is a salivary gland neoplasm that shares a genetic mutation with certain types of breast cancer. MASCSG was first described by ... Mammary analogue secretory carcinoma occurs somewhat more commonly in men (male to female ratio of ... This mutant fusion gene also occurs in congenital fibrosarcoma, congenital mesoblastic nephroma, secretory breast cancer (also ... a subtype of invasive ductal carcinoma of the breast. The translocation found in MASCSG occurs between the ETV6 gene located on ...

https://en.wikipedia.org/wiki/Mammary_analogue_secretory_carcinoma

... hCG was discovered to be expressed in certain kinds of malignant neoplasms, including breast cancer, adenocarcinoma of the ... The smaller gamete is the sperm cell and is produced by males of the species. The larger gamete is the ovum and is produced by ... Immunocontraception targeting the male gamete has involved many different antigens associated with sperm function. The zona ... In this way antibodies generated by the male are deposited into the female along with spermatozoa. Because of this and the ...

https://en.wikipedia.org/wiki/Immunocontraception

Receptor Positive Breast Tumor Subtypes". Journal of Breast Cancer. 20 (2): 198-202. doi:10.4048/jbc.2017.20.2.198. PMC 5500404 ... MORT RNA expression and DNA methylation state were evaluated in the 10 most common male cancers and the 10 most common female ... lymphoid neoplasm diffuse large B-cell lymphoma, pancreatic adenocarcinoma, rectum adenocarcinoma, skin cutaneous melanoma, and ... Indeed, recent work has shown that MORT is epigenetically silenced in both DCIS, a premalignant lesion of invasive breast ...

https://en.wikipedia.org/wiki/MORT_(long_non-coding_RNA)

... is almost twice as common in men than in women, and is usually diagnosed in individuals aged 53 ... It is likely directly induced by an underlying neoplasm secreting a growth factor. One candidate may be alpha-transforming ... FCP is associated with underlying cancer of the breast, bladder, ovary, uterus, prostate, and lung. Other associated underlying ... 2005). "Florid cutaneous papillomatosis with adenocarcinoma of stomach in a 35 year old male" (PDF). Indian J Dermatol Venereol ...

https://en.wikipedia.org/wiki/Florid_cutaneous_papillomatosis

Szabo S, Haislip A, Garry R (2005). "Of mice, cats, and men: is human breast cancer a zoonosis?". Microsc Res Tech. 68 (3-4): ... A mammary tumor is a neoplasm originating in the mammary gland. It is a common finding in older female dogs and cats that are ... They occur in male and female rats. The tumors can be large and occur anywhere on the trunk. There is a good prognosis with ... There is a much lower risk (about 1 percent) in male dogs and a risk in cats about half that of dogs. The exact causes for the ...

https://en.wikipedia.org/wiki/Mammary_tumor

It is also used to treat breast development and small penis in males.[1] It is typically given as a gel for application to the ... "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Sartorelli AC, Johns DJ (eds.). Antineoplastic ... Notes: Men produce about 3 to 11 mg testosterone per day (mean 7 mg/day in young men). Footnotes: a = Never marketed. b = No ... breast atrophy, and muscle hypertrophy, as well as menstrual disturbances and reversible infertility.[35][36] In men, the ...

https://en.wikipedia.org/wiki/Androstanolone

G1 and G2 neuroendocrine neoplasms are called neuroendocrine tumors (NETs) - formerly called carcinoid tumours. G3 neoplasms ... Carney Complex, type 1; CNC1 (OMIM 160980) omim.org OMIM - Online Mendelian Inheritance in Man. Carney Complex, type 2; CNC2 ( ... Soga, J.; Osaka, M.; Yakuwa, Y. (2001). "Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: An ... Although there are many kinds of NETs, they are treated as a group of tissue because the cells of these neoplasms share common ...

https://en.wikipedia.org/wiki/Neuroendocrine_tumor

Insertion of Male Urethral Catheter Chapter CP10: Clinical Procedures Tutorial: Fine Needle Aspiration of Breast Cyst Chapter ... Neoplasms of the Lung Chapter 75: Breast Cancer Chapter 76: Upper Gastrointestinal Tract Cancers Chapter 77: Lower ... He who uses these with courage, humility and wisdom will provide a unique service to his fellow man and will build an enduring ... Men's Health Chapter 393: Lesbian, Gay, Bisexual, and Transgender (LGBT) Health Section 3: Obesity, Diabetes Mellitus, and ...

https://en.wikipedia.org/wiki/Harrison's_Principles_of_Internal_Medicine

Secondary bone tumors are metastatic lesions which have spread from other organs, most commonly carcinomas of the breast, lung ... Some benign tumors are not true neoplasms, but rather, represent hamartomas, namely the osteochondroma. The most common ... penis/testes in males and vagina/vulva in females). This operation is done in two stages. First stage is doing the colostomy ... Carcinomas of the prostate, breasts, lungs, thyroid, and kidneys are the carcinomas that most commonly metastasize to bone. ...

https://en.wikipedia.org/wiki/Bone_tumor

The therapeutic use of 89Sr was only approved in 1993 for the palliative treatment of breast and prostate cancers metastatic to ... Annotated bibliography of strontium and calcium metabolism in man and animals. Washington, DC: United States Department of ... Radioactive strontium for treating incurable pain in skeletal neoplasms]. Deutsche Medizinische Wochenschrift (in German). 98 ( ... This palliative treatment for breast and prostate cancers metastatic to the bones was only approved by the Food and Drug ...

https://en.wikipedia.org/wiki/Charles_Pecher

... male limited Preeclampsia Preeyasombat Viravithya syndrome Pregnancy toxemia /hypertension Prekallikrein deficiency, congenital ... familial Pancreatic diseases Pancreatic islet cell neoplasm Pancreatic islet cell tumors Pancreatic lipomatosis duodenal ... syndrome Paget disease extramammary Paget disease juvenile type Paget's disease of bone Paget's disease of the breast Paget's ... see Anorectal malformation Pseudohermaphroditism female skeletal anomalies Pseudohermaphroditism male with gynecomastia ...

https://en.wikipedia.org/wiki/List_of_diseases_(P)

Myxomas may also occur outside the heart, usually in the skin and breast. Endocrine tumors may manifest as disorders such as ... Online Mendelian Inheritance in Man (OMIM) Carney Complex, type 1; CNC1 -160980 Stratakis, C. A.; Kirschner, L. S.; Carney, J. ... Epithelioid blue nevus List of cutaneous neoplasms associated with systemic syndromes Carney Syndrome at eMedicine Carney, J.; ... Online Mendelian Inheritance in Man (OMIM) Carney Complex, type 2; CNC2 -605244 Tsay CJ, Stratakis CA, Faucz FR, London E, ...

https://en.wikipedia.org/wiki/Carney_complex

Isabel Woodman, "Breast feeding reduces risk of breast cancer, says study," British Medical Journal, v.); Jul 27, 2002 ... For example, the FGR 13 has estimated that the ratio of thyroid cancer incidence for women as compared to men is 2.14, while ... Several severe adverse health effects, such as an increased incidence of cancers, thyroid diseases, CNS neoplasms, and possibly ... However, women develop cancer from radiation at a rate from 37.5% to 52% higher than that of men. In recent years, studies ...

https://en.wikipedia.org/wiki/Downwinders

Male breast cancer. *Melanoma. *Merkel-cell carcinoma. *Mesothelioma. *Metastasis. *Metastatic breast cancer ... Salivary gland neoplasm. *Sarcoma. *Skin cancer. *Small intestine cancer. *Small-cell carcinoma ...

https://simple.wikipedia.org/wiki/Category:Cancer

... particularly for breast cancer. The difference between breast cancer recurrence in patients who receive radiotherapy vs. those ... In males previously having undergone radiotherapy, there appears to be no increase in genetic defects or congenital ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ... 2005). "Breast cancer". In Gerbaulet A, Pötter R, Mazeron J, Limbergen EV. The GEC ESTRO handbook of brachytherapy. Belgium: ...

https://en.wikipedia.org/wiki/Radiation_therapy

A Crisis in Men's Health. National Prostate Cancer Coalition; 2007 Webcite. *^ "Breast cancer receives much more research ... "Male Genitals - Prostate Neoplasms". Pathology study images. University of Virginia School of Medicine. Archived from the ... of men in their fifties, and in 80% of men in their seventies.[19] Men who have first-degree family members with prostate ... prostate cancer more commonly affects black men than white or Hispanic men, and is also more deadly in black men.[26][27] In ...

https://fa.wikipedia.org/wiki/سرطان_پروستات?match=en

For women and men over age 18 the PRI is set at 330 μg/day. PRI for pregnancy is 600 μg/day, for lactation 500 μg/day. For ... Chronically insufficient intake of folic acid may increase the risk of colorectal, breast, ovarian, pancreas, brain, lung, ... Folate deficiency hinders DNA synthesis and cell division, affecting hematopoietic cells and neoplasms the most because of ... The 2013-2014 survey reported that for adults ages 20 years and older, men consumed on average of 249 μg/d folate from food ...

https://en.wikipedia.org/wiki/Vitamin_b9

Don Meyer, head coach emeritus of the Northern State University men's basketball team. Professor Meyer was found to have ... cystic neoplasms: Serous microcystic adenoma. *Intraductal papillary mucinous neoplasm. *Mucinous cystic neoplasm ... Paget's disease of the breast / Extramammary Paget's disease. Lobular carcinoma. *Lobular carcinoma in situ ... "Case 35-2008 - A 65-Year-Old Man with Confusion and Memory Loss". N Engl J Med. 359 (20): 2155-2164. doi:10.1056/ ...

https://en.wikipedia.org/wiki/Gastrointestinal_carcinoid_tumor

Secondary neoplasm[edit]. Development of secondary neoplasia after successful chemotherapy or radiotherapy treatment can occur ... A woman being treated with docetaxel chemotherapy for breast cancer. Cold mittens and wine coolers are placed on her hands and ... In males previously having undergone chemotherapy or radiotherapy, there appears to be no increase in genetic defects or ... Can G, Demir M, Erol O, Aydiner A (Jun 2013). "A comparison of men and women's experiences of chemotherapy-induced alopecia". ...

https://en.wikipedia.org/wiki/Chemotherapeutics

"Neoplasms and cancer" has been chosen to reflect the fact that not all tumours are benign. The word "cancer" has been included ... Template:Breast navs(edit talk links history). *Template:Cell navs(edit talk links history) ...

https://kn.wikipedia.org/wiki/ಟೆಂಪ್ಲೇಟು:Central_nervous_system_navs

The skull bone structure can also be subject to a neoplasm that by its very nature reduces the volume of the intracranial ... Deaths as a result of brain cancer were 5.3 per 100 000 for males, and 3.6 per 100 000 for females, making brain cancer the ... breast cancer, malignant melanoma, kidney cancer, and colon cancer (in decreasing order of frequency). ... "CNS and Miscellaneous Intracranial and Intraspinal Neoplasms" (PDF). SEER Pediatric Monograph. National Cancer Institute. pp. ...

https://en.m.wikipedia.org/wiki/Brain_tumor

For instance, CMF-therapy for breast cancer (where the cumulative dose is typically less than 20 grams of cyclophosphamide) ... Bernatsky S, Clarke AE, Suissa S (February 2008). "Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis ... has been found to significantly increase the risk of premature menopause in females and of infertility in males and females, ... breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.[4] As an immune suppressor it is used in nephrotic syndrome ...

https://en.m.wikipedia.org/wiki/Cyclophosphamide

male. *female. *Neoplasms and cancer *male. *female. *gonadal. *germ cell. *Other *male ... টেমপ্লেট:Diseases of the pelvis, genitals and breasts *দে. *স. যৌনবাহিত সংক্রমণ অথবা যৌনব্যাধি-সংক্রান্ত রোগ (STD and STI) ( ...

https://bn.wikipedia.org/wiki/শ্রোণীর_প্রদাহ_রোগ

In the male breast, fibroepithelial tumors are very rare, and are mostly phyllodes tumors. Exceptionally rare case reports ... These tumors characteristically display hypovascular stroma compared to malignant neoplasms.[2][12][9] Furthermore, the ... Fibroadenomas are sometimes called breast mice or a breast mouse owing to their high mobility in the breast.[3] ... Shin SJ, Rosen PP (July 2007). "Bilateral presentation of fibroadenoma with digital fibroma-like inclusions in the male breast ...

https://en.m.wikipedia.org/wiki/Fibroadenoma

This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer.[19] The ... Horn, L; Lovly, CM; Johnson, DH (2015). "Chapter 107: Neoplasms of the lung". In Kasper, DL; Hauser, SL; Jameson, JL; Fauci, AS ... breast cancer that has spread to the lung is called metastatic breast cancer. Metastases often have a characteristic round ... In the United States, black men and women have a higher incidence.[153] Lung cancer rates are currently lower in developing ...

https://en.wikipedia.org/wiki/Lung_cancer

... for breast cancer after breast-conserving surgery, radiotherapy has been found to halve the rate at which the disease recurs.[7 ... In males previously having undergone radiotherapy, there appears to be no increase in genetic defects or congenital ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ... "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of ...

https://en.m.wikipedia.org/wiki/Radiotherapy

One in 19 men and one in 28 women in Australia will develop colorectal cancer before the age of 75; one in 10 men and one in 15 ... Srikumar Chakravarthi; Baba Krishnan; Malathy Madhavan (1999). "Apoptosis and expression of p53 in colorectal neoplasms". ... "Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: ... As of 2012[update], it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men ...

https://en.m.wikipedia.org/wiki/Colon_cancer

Glandular and epithelial neoplasms (ICD-O 8010-8589). Epithelium. Papilloma/carcinoma. (8010-8139). *Small cell carcinoma ... Paget's disease of the breast / Extramammary Paget's disease. Lobular carcinoma. *Lobular carcinoma in situ ...

https://en.wikipedia.org/wiki/Somatostatinoma

Diseases of the skin include skin infections and skin neoplasms (including skin cancer).[28] ... Mammillated: with rounded, breast-like projections. *Reticular or reticulated: resembling a net ... Androgenic alopecia (male-pattern baldness). *Hypotrichosis. *Telogen effluvium. *Traction alopecia. *Lichen planopilaris ...

https://en.wikipedia.org/wiki/Cutaneous_conditions

For women and men over age 18 the PRI is set at 330 μg/day. PRI for pregnancy is 600 μg/day, for lactation 500 μg/day. For ... Folate deficiency hinders DNA synthesis and cell division, affecting hematopoietic cells and neoplasms the most because of ... breast, ovarian, pancreas, brain, lung, cervical, and prostate cancers.[7][39][40][41][42] Other studies showed that excessive ... Men consume more folate (in dietary folate equivalents) than women, and non-Hispanic whites have higher folate intakes than ...

https://en.wikipedia.org/wiki/Folacin

"Stone age man used dentist drill". BBC News. 6 April 2006. Retrieved 24 May 2010.. ... Operations/surgeries and other procedures of the breast (ICD-9-CM V3 85, ICD-10-PCS 0H) ...

https://kn.wikipedia.org/wiki/ಶಸ್ತ್ರಚಿಕಿತ್ಸೆ

... for breast cancer after breast-conserving surgery, radiotherapy has been found to halve the rate at which the disease recurs.[7 ... In males previously having undergone radiotherapy, there appears to be no increase in genetic defects or congenital ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ... "Breast Cancer: Targets and Therapy. 9: 257-263. doi:10.2147/BCTT.S112516. PMC 5402914. PMID 28458578.. ...

https://en.wikipedia.org/wiki/Radiation_oncology

Tumors: Skin neoplasm, skin appendages / Adnexal and skin appendage (C44.L40-L68/D23.L15-49, 173/216) ... In the case of an elderly frail man with multiple complicating medical problems, a difficult to excise basal-cell cancer of the ... Paget's disease of the breast, atypical fibroxanthoma, leiomyosarcoma, and angiosarcoma. ... Tumors: Skin neoplasm, nevi and melanomas (C43/D22, 172/216, ICD-O 8720-8799) ...

https://en.wikipedia.org/wiki/Skin_cancer

Male breast cancer. *Phyllodes tumor. *Inflammatory Breast Cancer. Endocrine system[edit]. *Adrenocortical carcinoma ... Multiple myeloma/plasma cell neoplasm. *Myelodysplastic syndromes. *Mucosa-associated lymphoid tissue lymphoma ... For example, the most common type of breast cancer is called ductal carcinoma of the breast. Here, the adjective ductal refers ... Nearly all cancers developing in the breast, prostate, lung, pancreas, and colon are carcinomas. ...

https://en.wikipedia.org/wiki/List_of_cancer_types

These were cancers of the brain, lung, bowel, breast, and bladder, and other neoplasms. Not only are benzodiazepines associated ... Hertz MM, Paulson OB (May 1980). "Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood- ... Breast feeding by mothers using nitrazepam is not recommended. Nitrazepam is a long-acting benzodiazepine with a risk of drug ... Kangas L, Kanto J, Siirtola T, Pekkarinen A (July 1977). "Cerebrospinal-fluid concentrations of nitrazepam in man". Acta ...

https://en.wikipedia.org/wiki/Nitrazepam

Male Genitals - Prostate Neoplasms»։ Pathology study images։ University of Virginia School of Medicine։ Արխիվացված է օրիգինալից ... breast and prostate cancer, epidemiological studies suggest little or no association between total fruit and vegetable ...

https://hy.m.wikipedia.org/wiki/Շագանակագեղձի_քաղցկեղ

... male, over-expectant, and narcissistic), which might indicate a man over-valuing the outcome of a rhinoplasty.[8] ... among its surgical techniques featured a breast reduction procedure.[6][7] ... Neoplasms - malignant and benign tumors. *Septal hematoma - a mass of (usually) clotted blood in the septum ... The nasolabial angle, the slope between the columella and the philtrum, is approximately 90-95 degrees in the male face, and ...

https://en.m.wikipedia.org/wiki/Rhinoplasty

"Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas". The Sol Goldman Pancreas Cancer Research Center. ... Globally pancreatic cancer is the 11th most common cancer in women and the 12th most common in men.[6] The majority of recorded ... breast, and lung. Surgery may be performed on the pancreas in such cases, whether in hope of a cure or to alleviate symptoms.[ ... Pancreatic mucinous cystic neoplasms are a broad group of pancreas tumors that have varying malignant potential. They are being ...

https://en.wikipedia.org/wiki/Pancreatic_cancer

Lead affects both the male and female reproductive systems. In men, when blood lead levels exceed 40 μg/dL, sperm count is ... Lead is able to pass through the placenta and into breast milk, and blood lead levels in mothers and infants are usually ... neoplasms of the central nervous system, emotional and behavior disorders, and intellectual disability.[23] ... Baselt, Randall Clint (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Biomedical Publications. pp. 823-6. ...

https://en.m.wikipedia.org/wiki/Lead_poisoning

Male Breast Neoplasms anonymous support group with inform... ... people sharing true stories in the I Have Male Breast Neoplasms ... Do You Have Male Breast Neoplasms? Join friendly ... I Have Male Breast Neoplasms does not have any stories yet. Be ... Male Breast Neoplasms anonymous support group with information on diagnosis, treatment, symptoms, along with personal stories ... and experiences with Male Breast Neoplasms. Youre not alone. Report Group. ...

http://www.experienceproject.com/groups/Have-Male-Breast-Neoplasms/98618

C50.422 Malignant neoplasm of upper-outer quadrant of left male breast C50.429 Malignant neoplasm of upper-outer quadrant of ... C50.322 Malignant neoplasm of lower-inner quadrant of left male breast C50.329 Malignant neoplasm of lower-inner quadrant of ... C50.42 Malignant neoplasm of upper-outer quadrant of breast, male C50.421 Malignant neoplasm of upper-outer quadrant of right ... C50.52 Malignant neoplasm of lower-outer quadrant of breast, male C50.521 Malignant neoplasm of lower-outer quadrant of right ...

https://www.icd10data.com/ICD10CM/Codes/C00-D49/C50-C50/C50-/C50.429

C50.322 Malignant neoplasm of lower-inner quadrant of left male breast C50.329 Malignant neoplasm of lower-inner quadrant of ... Malignant neoplasm of lower-inner quadrant of unspecified male breast. 2016 2017 2018 2019 2020 Billable/Specific Code Male Dx ... C50.222 Malignant neoplasm of upper-inner quadrant of left male breast C50.229 Malignant neoplasm of upper-inner quadrant of ... C50.32 Malignant neoplasm of lower-inner quadrant of breast, male C50.321 Malignant neoplasm of lower-inner quadrant of right ...

https://www.icd10data.com/ICD10CM/Codes/C00-D49/C50-C50/C50-/C50.329

Male Breast , Male Breast Cancer , Male Breast Carcinoma , Male Breast Neoplasm , Male Breast Neoplasms , Male Breast Tumor , ... Male Breast Tumors , Neoplasm, Male Breast , Neoplasms, Breast, Male , Neoplasms, Male Breast , Tumor, Male Breast , Tumors, ... Breast Neoplasms, Male Synonyms Breast Cancer, Male , Breast Carcinoma, Male , Breast Neoplasm, Male , Breast Tumor, Male , ... Diseases ← Neoplasms ← Neoplasms by Site ← Breast Neoplasms ← Breast Neoplasms, Male 2.. Diseases ← Skin and Connective Tissue ...

http://ctdbase.org/detail.go?type=disease&acc=MESH%3AD018567

Here, we report the case of a 57-year-old man who was referred to our institution with synchronous squamous cell carcinoma of ... To the best of our knowledge, this is the first reported case in literature of this combination of primary neoplasms. ... the skin on the forehead, infiltrating ductal carcinoma of the breast, and transitional cell carcinoma of the urinary bladder. ... The incidence of multiple primary malignant neoplasms increases with age, reflecting an increase in overall cancer risk in ...

https://wjso.biomedcentral.com/articles/10.1186/1477-7819-11-282

Breast Neoplasm. *Breast Neoplasm, Male. *Triple Negative Breast Cancer. *Drug: Cyclophosphamide. *Drug: Indomethacin ... Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer. *Malignant Neoplasm of Breast ... Comparison of the Breast Tumor Microenvironment. *Triple Negative Breast Cancer. *Hormone Receptor Positive Malignant Neoplasm ... Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR. *Breast Neoplasms ...

https://clinicaltrials.gov/ct2/results?recr=open&cond=%22Breast+Neoplasms%22+AND+%22Breast+Diseases%22&show_down=Y

... male (C5042). This code is grouped under diagnosis codes for neoplasms. ... ICD-10 C50.42 is malignant neoplasm of upper-outer quadrant of breast, ... Malignant neoplasm of axillary tail of right male breast. 62. C50.622. Malignant neoplasm of axillary tail of left male breast ... Malignant neoplasm of central portion of breast, male. 17. C50.121. Malignant neoplasm of central portion of right male breast ...

http://healthprovidersdata.com/hipaa/codes/ICD10-C50.42

... male (C5032). This code is grouped under diagnosis codes for neoplasms. ... ICD-10 C50.32 is malignant neoplasm of lower-inner quadrant of breast, ... Malignant neoplasm of axillary tail of right male breast. 62. C50.622. Malignant neoplasm of axillary tail of left male breast ... Malignant neoplasm of central portion of breast, male. 17. C50.121. Malignant neoplasm of central portion of right male breast ...

http://healthprovidersdata.com/hipaa/codes/ICD10-C50.32

... a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF Mod Pathol ... Excised fresh breast tissue for evaluation and/or treatment of a variety of breast lesions were sampled by FNA technique and ... Breast Neoplasms / metabolism* * Colonic Neoplasms / diagnosis * Colonic Neoplasms / metabolism * Female * Humans * Male ... In conclusion, FNA of breast tissue placed in PreservCyt is a potentially acceptable method of sample handling for evaluation ...

https://pubmed.ncbi.nlm.nih.gov/15195106/?dopt=Abstract

Breast cancer in male patient has a worse prognosis than female patients, due to lower amount of tissue in breast exposed to an ... 53 -year-old male diagnosed with right breast cancer, infiltrating ductal adenocarcinoma type, clinical stage IIB, breast ... Male breast cancer is a rare entity, with an approximate rate of 1.1 / 100 000 in the US, with an average age of 67 years. In ... Breast cancer in males, case presentation and literature review. [Article in Spanish; Abstract available in Spanish from the ...

https://www.ncbi.nlm.nih.gov/pubmed/30521157

The ICD-10 Code C50.029 is the code used for Malignant neoplasm of nipple and areola, unsp male breast .An alternative ... description for this code is Malignant neoplasm of nipple and areola, unspecifi. ...

http://medpricemonkey.com/icd10_code?icd10_code=C50.029

The ICD-10 Code C50.121 is the code used for Malignant neoplasm of central portion of right male breast .An alternative ... description for this code is Malignant neoplasm of central portion of right mal. ...

http://medpricemonkey.com/icd10_code?icd10_code=C50.121

C50.92 Malignant neoplasm of breast of unspecified site, male NON-BILLABLE * * BILLABLE C50.921 Malignant neoplasm of ... BILLABLE C50.922 Malignant neoplasm of unspecified site of left male breast * BILLABLE C50.929 Malignant neoplasm of ... Malignant neoplasm of breast of unspecified site, male NON-BILLABLE Non-Billable Code Non-Billable means the code is not ... ICD-10-CM Alphabetical Index References for C50.92 - Malignant neoplasm of breast of unspecified site, male The ICD-10-CM ...

https://icd.codes/icd10cm/C5092

Breast Neoplasms, Male. D018567. EFO:0006861. male breast carcinoma. 2. ClinicalTrials. Carcinoma, Non-Small-Cell Lung. D002289 ... Breast Neoplasms. D001943. EFO:0000305. breast carcinoma. 2. ClinicalTrials. ClinicalTrials. Colonic Neoplasms. D003110. EFO: ... Uterine Neoplasms. D014594. EFO:0003859. uterine neoplasm. 1. ClinicalTrials. Acute Lung Injury. D055371. EFO:0004610. acute ... Neoplasms. D009369. EFO:0000616. neoplasm. 4. ClinicalTrials. ATC. ClinicalTrials. Histiocytoma. D051642. EFO:0005561. ...

https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941

Malignant neoplasm of unspecified site of left male breast BILLABLE Billable Code Billable codes are sufficient justification ... C50.922 is a billable ICD code used to specify a diagnosis of malignant neoplasm of unspecified site of left male breast. A ... Malignant neoplasm of other and unspecified sites of male breast (approximate match) ... The ICD code C50 is used to code Urogenital neoplasm A urogenital neoplasm is a tumor of the urogenital system. ...

https://icd.codes/icd10cm/C50922

Male Breast Cancer Although breast cancer is much more common in women, men can get it too. It happens most often to men ... Neoplasms (C00-D48) * Malignant neoplasms of breast (C50) * Malignant neoplasm of breast (C50) ... unsp male breast Long Description: Malignant neoplasm of nipple and areola, unspecified male breast This is the 2019 version of ... C50.029 - Malignant neoplasm of nipple and areola, unsp male breast. ICD-10 Diagnosis Code C50.029. Malignant neoplasm of ...

https://icdlist.com/icd-10/C50.029

Breast Neoplasms, Male. Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. Paclitaxel. Liposomal ... Male Breast Carcinoma Stage IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA ... Margins of breast conservation surgery or mastectomy must be histologically free of invasive breast cancer and ductal carcinoma ... Accelerated partial breast radiation (APBI) after chemotherapy. *Accelerated partial breast radiation (APBI) prior to ...

https://clinicaltrials.gov/ct2/show/NCT00433511?cond=%22Breast+Neoplasms%2C+Male%22&rank=18

Breast Neoplasms Breast Diseases Neoplasms Neoplasms by Site Fulvestrant Antineoplastic Agents Antineoplastic Agents, Hormonal ... Breast Neoplasms. Neoplasms. Breast Diseases. Neoplasms by Site. Skin Diseases. Fulvestrant. Estradiol. Antineoplastic Agents, ... Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. (MONALEESA-3). The safety ... placebo controlled trial in men and post-menopausal women with advanced breast cancer. ...

https://www.clinicaltrials.gov/ct2/show/NCT02422615?term=NCT02422615&rank=1

C50.329 is a billable code used to specify a medical diagnosis of malignant neoplasm of lower-inner quadrant of unspecified ... Male Breast Cancer Although breast cancer is much more common in women, men can get it too. It happens most often to men ... Neoplasms (C00-D48) * Malignant neoplasms of breast (C50) * Malignant neoplasm of breast (C50) ... Malig neoplasm of lower-inner quadrant of unsp male breast. Long Description:. Malignant neoplasm of lower-inner quadrant of ...

https://icdlist.com/icd-10/C50.329

Although breast cancer is much more common in women, men can get it too. Learn more. ... Did you know that men can get breast cancer? ... ClinicalTrials.gov: Breast Neoplasms, Male (National Institutes ... Breast Cancer in Men (Susan G. Komen for the Cure) * General Information about Male Breast Cancer (National Cancer Institute) ... How Is Breast Cancer in Men Diagnosed? (American Cancer Society) * Stages of Male Breast Cancer (National Cancer Institute) ...

https://medlineplus.gov/malebreastcancer.html

Triple Negative Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. Genital Neoplasms, Male. ... Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer. The safety and ... AR positive breast cancer and men with ER positive breast cancer. The study consists of five cohorts: patients in Cohort 1 must ... Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer. ...

https://www.clinicaltrials.gov/ct2/show/study/NCT02130700?term=Oral+Cancer&recrs=a&fund=0&rank=21

In particular, one segregation analysis of breast cancer suggested that disease susceptibility in noncarriers of BRCA1/2 ... Susceptibility to breast cancer is likely to be the result of susceptibility alleles in many different genes. ... Breast Neoplasms / epidemiology * Breast Neoplasms / genetics* * Data Interpretation, Statistical * Female * Humans * Male ... Polygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol. 2003 Nov;25(3):190-202. ...

https://pubmed.ncbi.nlm.nih.gov/14557987/?dopt=Abstract

Breast Neoplasms, Breast Tumors, Breast Cancer, Mammary Cancer and Malignant Tumor of Breast. We searched for additional ... Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst ... male breast cancer has been reported" and "The relationship between long-term use of finasteride and male breast neoplasia is ... The small number of cases with male breast cancer and the lack of information on some known risk factors for male breast cancer ...

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000500865&lng=pt&tlng=en

Tomosynthesis is an innovative technique developed in digital mammography for obtaining a sectional image of the breast. Ma... ... Breast Neoplasms, Male. Any neoplasms of the male breast. These occur infrequently in males in developed countries, the ... Triple Negative Breast Neoplasms. Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not ... Breast Cancer Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to ...

https://www.bioportfolio.com/resources/trial/169580/Evaluation-of-Tomosynthesis-for-Characterization-and-the-Management-of-Breast-Lesions.html

Malignant breast neoplasms occur more frequently in females than in males. [from NCI]. ... Neoplasm of the breast. Breast cancer is a disease in which certain cells in the breast become abnormal and multiply ... Malignant Breast Neoplasm. A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are ... Although breast cancer is much more common in women, this form of cancer can also develop in men. In both women and men, the ...

https://www.ncbi.nlm.nih.gov/medgen?LinkName=pubmed_medgen&from_uid=18096313

Breast Neoplasms* / cerebrospinal fluid. Female. Humans. Image Enhancement. Magnetic Resonance Imaging*. Male. Meningeal ... 2208009 - Brush cytology in the diagnosis of colonic neoplasms.. 15762059 - Comparison of bronchoalveolar lavage cytology and ... 7828229 - Aspiration cytology of breast lumps.. 12203219 - Atypical blasts and bone marrow necrosis associated with near- ... and the most frequent primary tumour was breast carcinoma (27/41). Two thirds of patients presented with at least one cranial ...

http://www.biomedsearch.com/nih/Imaging-features-leptomeningeal-metastases/10580769.html

Breast Neoplasms, Male. Any neoplasms of the male breast. These occur infrequently in males in developed countries, the ... Triple Negative Breast Neoplasms. Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not ... delayed puberty in males, and in the treatment of breast neoplasms in women. ... Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, ...

https://www.bioportfolio.com/resources/trial/129319/Lux-Breast-3-Afatinib-Alone-or-in-Combination-With-Vinorelbine-in-Patients.html

Stage IIIC Breast Cancer. *Stage IV Breast Cancer. *Breast Neoplasms. *Breast Neoplasms, Male ... Male Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer ... metastatic breast cancer. (Phase II). SECONDARY OBJECTIVES:. I. To determine whether in vivo treatment with vorinostat induces ... breast; effective with version 2.2 (1/26/09), only patients with disease that is. accessible to biopsy and consent to serial ...

http://www.knowcancer.com/cancer-trials/NCT00368875/

... trial is studying the side effects of escalating doses of adoptive T cell therapy in treating patients with stage IV breast ... Recurrent Breast Cancer. *Stage IV Breast Cancer. *Breast Neoplasms. *Breast Neoplasms, Male ... HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer ... advanced HER2+ breast cancer.. II. To determine whether indium-labeled HER-2 specific T-cells traffic to sites of. metastatic ...

http://www.knowcancer.com/cancer-trials/NCT00791037/

Here, we report the case of a 57-year-old man who was referred to our institution with synchronous squamous cell carcinoma of the skin on the forehead, infiltrating ductal carcinoma of the breast, and transitional cell carcinoma of the urinary bladder. (biomedcentral.com)
In this report, we describe the case of a patient who developed synchronous primary transitional cell carcinoma (TCC) of the urinary bladder, squamous cell carcinoma (SCC) of the skin on the forehead, and infiltrating ductal breast carcinoma. (biomedcentral.com)
Retrospective part: males with histologically proven invasive breast carcinoma diagnosed since 1990 to 2010. (clinicaltrials.gov)
The ICD-10-CM code C50.329 might also be used to specify conditions or terms like carcinoma of breast - lower, inner quadrant or malignant neoplasm of breast lower inner quadrant or primary malignant neoplasm of breast lower inner quadrant. (icdlist.com)
The average age was 48 years, and the most frequent primary tumour was breast carcinoma (27/41). (biomedsearch.com)
Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, intraductally. (bioportfolio.com)
A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. (nih.gov)
Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. (nih.gov)
Male breast cancer is most commonly invasive ductal or ductal carcinoma in situ (DCIS). (medscape.com)
Breast cancers can arise in the lobes or lobules (lobular carcinoma) or in the ducts (ductal carcinoma) of the breast. (thefreedictionary.com)
Lobular carcinoma often affects both breasts. (thefreedictionary.com)
Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. (medscape.com)
Prostate carcinoma is among the most common solid tumors to secondarily involve the male breast. (pubmedcentralcanada.ca)
PSA expression has been reported in male and female breast carcinoma and in gynecomastia, raising concerns about the utility of PSA for differentiating prostate carcinoma metastasis to the male breast from primary breast carcinoma. (pubmedcentralcanada.ca)
This study examined the frequency of PSA, PSAP, and hormone receptor expression in male breast carcinoma (MBC), female breast carcinoma (FBC), and gynecomastia. (pubmedcentralcanada.ca)
PSA and PSAP are useful markers to distinguish primary breast carcinoma from prostate carcinoma metastatic to the male breast. (pubmedcentralcanada.ca)
Primary carcinoma of the male breast accounts for less than 1% of cancers in men[ 1 , 2 ]. (pubmedcentralcanada.ca)
In one study, 26% of patients with a known history of prostate carcinoma were found to have metastases to the breast at autopsy[ 6 ]. (pubmedcentralcanada.ca)
Reports of prostate specific antigen (PSA) expression in male and female breast carcinomas[ 3 , 10 - 15 ] have raised questions about the value of PSA staining in differentiating metastatic prostatic carcinoma from primary breast carcinoma. (pubmedcentralcanada.ca)
The aim of this study was to assess the frequency of PSA and prostate specific acid phosphatase (PSAP) expression in male breast carcinoma (MBC), female breast carcinoma (FBC) and gynecomastia and to correlate these findings with hormone receptor expression. (pubmedcentralcanada.ca)
Thus, ductal carcinoma in situ is considered a minimal breast cancer. (thefreedictionary.com)
Breast carcinoma is the most common malignant tumors in women in the world. (oatext.com)
While intraductal cancer, inflammatory carcinoma, and Paget's disease of the nipple have been described, lobular carcinoma in situ has not been seen in males. (wikipedia.org)
Studies investigating the detection of mRNA by RT-PCR from circulating carcinoma cells in the peripheral blood of breast cancer patients have shown that mammaglobin is a highly specific marker and correlates with several prognostic factors, such as lymph node involvement. (ox.ac.uk)
Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW, Tormey DC, Veeder M, Falkson G. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. (harvard.edu)
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. (harvard.edu)
A hormone used to treat hypogonadism, breast carcinoma in women, or the vasomotor symptoms of menopause. (drugbank.ca)
Histological examination of resected breast tissue showed infiltrating ductal carcinoma (grade III). (bmj.com)

A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. (icd10data.com)
To code a diagnosis of this type, you must use one of the three child codes of C50.92 that describes the diagnosis 'malignant neoplasm of breast of unspecified site, male' in more detail. (icd.codes)
C50.922 is a billable ICD code used to specify a diagnosis of malignant neoplasm of unspecified site of left male breast. (icd.codes)
C50.329 is a billable code used to specify a medical diagnosis of malignant neoplasm of lower-inner quadrant of unspecified male breast. (icdlist.com)
A primary or metastatic malignant neoplasm involving the breast. (nih.gov)
Breast Cancer (Malignant neoplasm) under a microscope! (giantmicrobes.com)
Breast cancer is the most common malignant neoplasm among women in the world [ 1 ]. (hindawi.com)
Example: Malignant neoplasm of the breast has 54 choices, and requires specification of male/female breast, the site of the neoplasm on the breast, and laterality. (aapc.com)
Code example: C50.411 Malignant neoplasm of upper-outer quadrant of the left female breast and Z17.1 Estrogen receptor status negative status [ER-] . (aapc.com)
Breast cancer incorporates ICD-10 cancer code C50 (Malignant neoplasm of breast). (canceraustralia.gov.au)

The incidence of multiple primary malignant neoplasms increases with age, reflecting an increase in overall cancer risk in older patients. (biomedcentral.com)
He did have a family history of malignancy though, as his father had developed rectal cancer and his sister had a kidney neoplasm. (biomedcentral.com)
Male breast cancer is a rare entity, with an approximate rate of 1.1 / 100 000 in the US, with an average age of 67 years. (nih.gov)
53 -year-old male diagnosed with right breast cancer, infiltrating ductal adenocarcinoma type, clinical stage IIB, breast cancer on 2 immediate family history, mutations of the BRCA1 gene and positive hormone receptors and Her2/Neu. (nih.gov)
Breast cancer in male patient has a worse prognosis than female patients, due to lower amount of tissue in breast exposed to an earlier chest spread and a different biological behavior, also a higher risk of prostate and pancreatic cancer is associated. (nih.gov)
Studies of adequate methodological quality are scarce, so that decisions are based on guidelines for breast cancer in women. (nih.gov)
Also searched for Breast Cancer and Breast carcinomas . (clinicaltrials.gov)
Although breast cancer is much more common in women, men can get it too. (icdlist.com)
Breast lumps usually aren't cancer. (icdlist.com)
However, most men with breast cancer have lumps. (icdlist.com)
Risk factors for male breast cancer include exposure to radiation, a family history of breast cancer, and having high estrogen levels, which can happen with diseases like cirrhosis or Klinefelter's syndrome. (icdlist.com)
Treatment for male breast cancer is usually a mastectomy, which is surgery to remove the breast. (icdlist.com)
Breast cancer Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor. (icdlist.com)
Although breast cancer is much more common in women, this form of cancer can also develop in men. (icdlist.com)
In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). (icdlist.com)
Most men have little or no lobular tissue, so lobular cancer in men is very rare.In its early stages, breast cancer usually does not cause pain and may exhibit no noticeable symptoms. (icdlist.com)
Having one or more of these symptoms does not mean that a person definitely has breast cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. (icdlist.com)
Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. (clinicaltrials.gov)
Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014). (clinicaltrials.gov)
Clinical and Biological Characterization of Male Breast Cancer: an International EORTC, BIG, TBCRC and NABCG Intergroup Study. (clinicaltrials.gov)
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. (clinicaltrials.gov)
This is a multi-center, randomized, double-blinded, placebo controlled trial in men and post-menopausal women with advanced breast cancer. (clinicaltrials.gov)
Can Breast Cancer in Men Be Found Early? (medlineplus.gov)
How Is Breast Cancer in Men Diagnosed? (medlineplus.gov)
The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17, in patients with castration-resistant prostate cancer (CRPC) who have been previously treated with Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men with ER positive Breast Cancer. (clinicaltrials.gov)
This is a Phase 2 open-label study of VT-464 in patients with progressive, metastatic castration-resistant prostate cancer (mCRPC) who have been previously treated with enzalutamide, female patients with triple negative, AR positive breast cancer and men with ER positive breast cancer. (clinicaltrials.gov)
Cohort 5 will consist of men who have been diagnosed with ER+ breast cancer and have failed at least one prior endocrine therapy. (clinicaltrials.gov)
Susceptibility to breast cancer is likely to be the result of susceptibility alleles in many different genes. (nih.gov)
In particular, one segregation analysis of breast cancer suggested that disease susceptibility in noncarriers of BRCA1/2 mutations may be explicable in terms of a polygenic model, with large numbers of susceptibility polymorphisms acting multiplicatively on risk. (nih.gov)
To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). (scielo.br)
The small number of breast cancer cases exposed to 5ARIs and the lack of an association in our study suggest that the development of breast cancer should not influence the prescribing of 5ARIs therapy. (scielo.br)
There have been 50 worldwide case reports of male breast cancer (MBC) in BPH patients aged from 54 to 88 years (mean age 71 years old), who received 5 mg finasteride until 2009, including twenty-seven cases that occurred after finasteride treatment for a minimum of 1 year. (scielo.br)
Patient information issued by the US Food and Drug Administration (FDA) for finasteride includes the following statements: "In rare cases, male breast cancer has been reported" and "The relationship between long-term use of finasteride and male breast neoplasia is currently unknown" ( 7 - 9 ). (scielo.br)
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. (bioportfolio.com)
Screening for breast cancer with tomosynthesis ma. (bioportfolio.com)
Mammography remains the current standard in the detection of breast cancer. (bioportfolio.com)
In March 2009, Health Canada approved Tomosynthesis for use in screening and diagnosis of breast cancer. (bioportfolio.com)
Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic? (bioportfolio.com)
To compare the efficacy of use of digital breast tomosynthesis (DBT) with standard digital mammography (DM) workup views in the breast cancer assessment clinic. (bioportfolio.com)
Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. (biomedsearch.com)
Furthermore, it has allowed detection of circulating PTHrP in hypercalcemic breast cancer patients with bone metastases, indicating a significant role for PTHrP in this disease. (biomedsearch.com)
I. To determine the recommended phase II dose of oral suberoylanilide hydroxyamic acid (vorinostat) in combination with weekly paclitaxel and bevacizumab in patients with chest wall recurrent or metastatic breast cancer. (knowcancer.com)
To determine the efficacy (response rate, response duration, time to disease progression, time to treatment failure, and overall survival) and toxicity of oral suberoylanilide hydroxyamic acid (vorinostat) in combination with weekly paclitaxel and bevacizumab in patients with chest wall recurrent or metastatic breast cancer. (knowcancer.com)
To determine whether in vivo treatment with vorinostat induces a) acetylation of proteins including histone H3 and H4, ubiquitylation of proteins, and c) the levels of Bim, Bak, tBID, p21 and p27 levels, as well as down regulate Bcl-2, Bcl-xL and survivin in chest wall recurrent or metastatic breast cancer cells (pre treatment vs. cycle 1 day 2 after 3 vorinostat doses but prior to paclitaxel). (knowcancer.com)
The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at time of enrollment and blood donation, 21 of whom have developed prostate cancer whilst on study. (whiterose.ac.uk)
The second group consisted of 283 female BRCA1/2 mutation carriers and controls (mean age 48 years), half of whom had been diagnosed with breast cancer prior to enrollment. (whiterose.ac.uk)
It is the first study investigating TL in a cohort of genetically predisposed males and although TL and BRCA status was previously studied in females our results don't support the previous finding of association between hereditary breast cancer and shorter TL. (whiterose.ac.uk)
As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. (nih.gov)
Breast Cancer affects 1 in every 8 women, but early detection and proper screening can help ensure the best outcomes. (giantmicrobes.com)
Your purchase of our Breast Cancer cell is supporting NBCF's early detection, education and support services. (giantmicrobes.com)
FACTS: Breast cancer usually begins as a lump that can be seen in a mammogram or felt when the breast is examined. (giantmicrobes.com)
However, risk-factors that increase the probability of developing the disease include a family history of breast or ovarian cancer, increasing age, never having breastfed, never having given birth, long-term hormone replacement therapy, and smoking. (giantmicrobes.com)
Men can get breast cancer, too. (giantmicrobes.com)
Although breast cancer is extremely serious, most people (approximately 80%) who get it survive, particularly if treatment is initiated early in the course of the disease before it has spread from its original site. (giantmicrobes.com)
Breast cancer is a cellular disease caused by uncontrolled division of abnormal cells in breast tissue. (giantmicrobes.com)
Male breast cancer is similar to breast cancer in females in its etiology, family history, prognosis, and treatment. (medscape.com)
In approximately 30% of cases of breast cancer in men, the family history is positive for the disease. (medscape.com)
A familial form of breast cancer is seen in which both genders are at increased risk for breast cancer. (medscape.com)
[ 16 ] The incidence of male breast cancer peaks at age 71 years. (medscape.com)
[ 17 ] Male breast cancer accounts for less than 0.1% of all canceers in men. (medscape.com)
The majority of male breast cancers are estrogen and progesterone receptor positive, as in female breast cancer. (medscape.com)
However, male breast cancer is 3 times less likely to be HER2 positive. (medscape.com)
If physical examination is suspicious for male breast cancer, mammography or digital breast tomosynthesis is recommended regardless of the patient's age. (medscape.com)
For patients at high risk of breast cancer (family history, genetic predisposition, personal history of breast cancer), recommendations include monthly breast self-examinations, semiannual clinical breast examinations, and baseline followed by yearly mammography if gynecomastia or breast density are seen. (medscape.com)
MRI is generally not indicated in the workup for male breast cancer unless there is concern for chest wall invasion. (medscape.com)
Features worrisome for female breast cancer are the same for male breast cancer: spiculated margins, washout enhancement kinetics, and abnormal lymphadenopathy. (medscape.com)
this is known breast cancer. (medscape.com)
Also, see eMedicineHealth's patient education articles Breast Cancer , Breast Lumps and Pain , and Breast Self-Exam . (medscape.com)
On mammography, male breast cancer is typically retroareolar as it arises from the central ducts. (medscape.com)
Calcifications are observed less commonly than in female breast cancer and, when found, are coarser in appearance. (medscape.com)
Mammography is highly sensitive and specific for breast cancer in men, but it should be used to complement the clinical examination. (medscape.com)
However, any confirmed increase in PSA while on dutasteride may signal the presence of prostate cancer and should be evaluated, even if those values are still within the normal range for untreated men. (nih.gov)
To receive news and publication updates for International Journal of Breast Cancer, enter your email address in the box below. (hindawi.com)
Chemotherapy, radiotherapy, and surgery are routine treatments of breast cancer. (hindawi.com)
Nowadays the combined therapy including herbals such as crocin is to study for improving breast cancer treatment. (hindawi.com)
Only in 2013 about 230,000 women and 2000 men were also added to this cancer society [ 2 ]. (hindawi.com)
In Iran, breast cancer has the highest incidence among malignancies in women. (hindawi.com)
It has been found that the incidence of breast cancer in Iran is less than that in developed countries. (hindawi.com)
Radiotherapy, chemotherapy, and surgery are the common treatment methods for breast cancer. (hindawi.com)
Breast cancer is the second leading cause of cancer death in women (following lung cancer lung cancer, cancer that originates in the tissues of the lungs. (thefreedictionary.com)
Lung cancer is the leading cause of cancer death in the United States in both men and women. (thefreedictionary.com)
Although the vast majority of the cases occur in women, some men also get breast cancer. (thefreedictionary.com)
Even allowing for improvements in detection (i.e., the introduction of routine mammography), there has been a long-term gradual increase in the incidence of breast cancer since the early 1970s, but because of the more effective treatment afforded by such early detection, overall mortality began to decrease by the mid-1990s. (thefreedictionary.com)
Epidemiological study has identified certain risk factors that increase the possibility that a woman will get breast cancer, although not all women with breast cancer have these traits, and many women with all of these traits do not develop the disease. (thefreedictionary.com)
and a history of breast cancer or benign proliferative breast disease. (thefreedictionary.com)
a coincident drop in the incidence of breast cancer tumors, especially estrogen-positive tumors, which apparently could not be accounted for by other causes, strongly suggested a link between the two. (thefreedictionary.com)
About 5% of women with breast cancer have an inherited susceptibility to the disease, and most of these women have an inherited mutation in one of two genes. (thefreedictionary.com)
In 1994 it was discovered that women who inherit a mutated BRCA1 gene have an almost 85% chance of developing breast cancer and an increased chance of developing uterine cancer. (thefreedictionary.com)
The defective gene can be inherited from either parent, but appears to cause breast cancer only in women. (thefreedictionary.com)
Young women who get breast cancer often come from families that carry a BRCA1 mutation. (thefreedictionary.com)
Pan-cancer survival analyses revealed a strong association between increased mutant p53 residual activity and improved survival in males with glioma and gastric adenocarcinoma ( P = 0.002 and P = 0.02) that was not present in the female cohorts ( P = 0.16 and P = 0.50). (jci.org)
Among germline TP53 mutation carriers, increased residual transcriptional activity is correlated with prolonged lifetime cancer survival and delayed tumor onset, and males are more prone to develop brain and gastric tumors. (jci.org)
Male Breast Cancer Survivor Spreads Awareness: 'Men Have Breasts, Too! (curetoday.com)
An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. (medscape.com)
Have a lifetime risk of breast cancer of 20 to 25 % or more using standard risk assessment models (BRCAPRO, Claus model, Gail model, or Tyrer-Cuzick). (aetna.com)
Aetna considers post-surgical intra-operative breast MRI for quantifying tumor deformation and detecting residual breast cancer experimental and investigational because its clinical value has not been established. (aetna.com)
Metastatic neoplasms to the breast generally occur in the setting of disseminated metastatic disease, however patients may present with a breast mass as the first manifestation of metastatic cancer[ 4 ]. (pubmedcentralcanada.ca)
Mainly taken from risk factors for breast cancer, risk factors can be described in terms of, for example: Relative risk, such as "A woman is more than 100 times more likely to develop breast cancer in her 60s than in her 20s. (wikipedia.org)
Fraction of incidences occurring in the group having the property of or being exposed to the risk factor, such as "99% of breast cancer cases are diagnosed in women. (wikipedia.org)
Does Hershey dark chocolate help save people from getting breast cancer? (answers.com)
What system does breast cancer affect? (answers.com)
What is the prognosis for Metastasised breast cancer in bones? (answers.com)
According to theNational Breast Cancer Foundation (NBCF), your symptoms atstage 4 will depend on the degree to which the cancer has spread inyour body. (answers.com)
Although metastatic breast cancer has no cure, it can betreated. (answers.com)
Did Michelle pfieffer have breast cancer? (answers.com)
Assessment of PD-L1 Expression by Digital Pathology demonstrates prognostic significance for overall survival in Triple Negative Breast Cancer and a novel association with overall survival in ER-/HER+ breast cancer. (qub.ac.uk)
Project HEAL is a series of three cancer early detection workshops (breast, prostate, colorectal) delivered through trained and certified lay peer community health advisors in African American churches. (centerwatch.com)
In a climate of limited resources, identifying sustainable and effective ways to increase cancer awareness and screening in African American men and women is more important than ever. (centerwatch.com)
Breast cancer is caused by the development of malignant cells in the breast. (thefreedictionary.com)
The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium), defining this malignancy as a cancer. (thefreedictionary.com)
Breast cancer arises in the milk-producing glands of the breast tissue. (thefreedictionary.com)
Depending on where in the glandular or ductal unit of the breast the cancer arises, it will develop certain characteristics that are used to sub-classify breast cancer into types. (thefreedictionary.com)
Breast cancer follows this classic progression though it often becomes systemic or widespread early in the course of the disease. (thefreedictionary.com)
When primary breast cancer spreads, it may first go to the axillary nodes. (thefreedictionary.com)
If breast cancer spreads to other major organs of the body, its presence will compromise the function of those organs. (thefreedictionary.com)
Although primary breast cancer is the most common malignancy of adult females, metastasis of breast cancer is rare, with a reported frequency of 0.4-1.3% in clinical series. (oatext.com)
Secondly, biopsy was carried out from the left breast excluding for second primary cancer and pathology reported as metastasis of lung adenocarcinoma. (oatext.com)
However, metastasis to the breast from extra mammary malignancies are rare, only accounts for 0.4-1.3% of all breast cancer [1,2]. (oatext.com)
It is very important to distinguish primary breast cancer from metastasis to breast, because the therapy offered would be different. (oatext.com)
Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. (wikipedia.org)
Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol use disorder and exposure to certain hormones and ionizing radiation. (wikipedia.org)
As it presents a similar pathology as female breast cancer, assessment and treatment relies on experiences and guidelines that have been developed in female patients. (wikipedia.org)
Breast cancer in males spreads via lymphatics and blood stream like female breast cancer. (wikipedia.org)
Accordingly, the TNM staging system for breast cancer is the same for males and females. (wikipedia.org)
In a larger study from Finland the average size of a male breast cancer lesion was 1.8 cm. (wikipedia.org)
Male breast cancer can recur locally after therapy, or can become metastatic. (wikipedia.org)
it is the same as in female breast cancer and facilitates treatment and analysis. (wikipedia.org)
Stage I is an invasive breast cancer with the tumor not exceeding 2 cm and absence of lymph node involvement. (wikipedia.org)
Stage III is divided into three subcategories: In IIIA there is breast cancer with axillary lymph nodes clumped together or attached to other structures. (wikipedia.org)
There are significant differences between male and female breast cancer in terms of physical symptoms, physiological and psychological responses, and experiences in health care. (wikipedia.org)
Almost half of male breast cancer patients are stage III or IV. (wikipedia.org)
With the relative infrequency of male breast cancer, randomized studies are lacking. (wikipedia.org)
Treatment largely follows patterns that have been set for the management of postmenopausal breast cancer. (wikipedia.org)
There were 828,997 DALYs due to cancer (20.5 DALYs/1,000 population), 61% in men. (biomedcentral.com)
Breast cancer is the most common cancer that affects women in the United States. (ndsu.edu)
There are at least two majors genes (BRCA1 and BRCA2) that when they mutate can cause breast cancer. (ndsu.edu)
There is a 90% chance of developing breast cancer for a woman that has these mutated genes. (ndsu.edu)
In contrast, men carrying BRCA1 have no risk to develop breast cancer, but those carrying BRCA2 genes have high risk. (ndsu.edu)
Hereditary cancer occurs at young age, for instance a woman in her 20's with breast cancer is more likely to have hereditary type of cancer that a woman in her 50's. (ndsu.edu)
Since the discovery of the BRCA1 and BRCA2 in 1994 and 1995 about 80% of the women who inherit mutated forms of these genes will develop breast cancer in their lifetime, usually at relatively early age and woman with BRCA1 mutations have a high risk of developing ovarian cancer as well. (ndsu.edu)
In September 1994, a new breast cancer susceptibility gene. (ndsu.edu)
Given the current stage of knowledge it is felt that these two genes together account for at least two thirds of familial breast cancer or roughly 5% of all cases. (ndsu.edu)
Analysis of more than 200 families worldwide has shown that the BRCA1 gene is probably linked to on third of families who present with multiple cases of breast alone, but more than 80% of families in which there are both breast cancer and ovarian cancer. (ndsu.edu)
The life time risk of breast cancer in BRCA1 mutations carriers is about 70% by the age 70 years. (ndsu.edu)
No male breast cancer cases have been seen in the BRCA1 family sets, whereas several cases are present in the BRCA2 families. (ndsu.edu)
Due to paucity of information on the mechanisms underlying inflammation -induced CRP dynamics, our model was developed by systematically evaluating several models for their ability to retrieve variable CRP profiles observed in IL-11-treated breast cancer patients. (curehunter.com)
Detection of mammaglobin mRNA in the plasma of breast cancer patients. (ox.ac.uk)
It has been suggested that mammaglobin may be a useful marker for breast cancer clinical research. (ox.ac.uk)
We aimed to detect cell-free mammaglobin mRNA in the plasma of breast cancer patients and to investigate whether it can be used as a marker for diagnosis of breast cancer. (ox.ac.uk)
The Food & Drug Administration has recorded thousands of deaths associated with Lupron, a puberty-blocking drug that is routinely used to treat prostate cancer in men and endometriosis in women. (christianpost.com)
Falkson G, Gelman RS, Pandya KJ, Osborne CK, Tormey D, Cummings FJ, Sledge GW, Abeloff MD. Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. (harvard.edu)
Falkson G, Gelman R, Glick J, Falkson CI, Harris J. Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study. (harvard.edu)
Falkson G, Gelman RS, Glick J, Falkson CI, Harris J. Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. (harvard.edu)
Falkson G, Gelman R, Falkson CI, Glick J, Harris J. Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. (harvard.edu)
pS2 expression and response to hormonal therapy in patients with advanced breast cancer. (harvard.edu)
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer. (harvard.edu)
Michael Kovarik describes his journey with male breast cancer as one of many ups and downs - fear, rage, hope, gratitude and strength. (patientpower.info)
He had early-stage breast cancer. (patientpower.info)
He had never heard of a man with breast cancer. (patientpower.info)
breast cancer in men makes up less than 1% of diagnoses. (patientpower.info)
Patient Power spoke to Kovarik about his breast cancer diagnosis, the stigma of male breast cancer and his message of hope for men newly diagnosed. (patientpower.info)
Women get breast cancer. (patientpower.info)
I had never heard of a man getting breast cancer. (patientpower.info)
How do we address the stigma associated with male breast cancer? (patientpower.info)
A medication used to treat advanced breast cancer. (drugbank.ca)
An aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen. (drugbank.ca)
A synthetic anabolic steroid used for the replacement therapy in conditions associated with testosterone deficiencies in males, such as hypogonadism, and treatment of advancing inoperable metastatic breast cancer in females. (drugbank.ca)
For the treatment of estrogen-receptor positive breast cancer in post-menopausal women. (drugbank.ca)
Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent. (drugbank.ca)
Breast Cancer Research and Treatment. (elsevier.com)
Breast cancer is a rare disease in men and represents only approximately 1% of all breast cancer cases. (bmj.com)
1 Several factors have been reported to increase the risk for male breast cancer, including alteration in hormonal status, Klinefelter's syndrome, family history of breast cancer, and occupational exposures to high temperature, electromagnetic fields, and radiation. (bmj.com)
2, 3 Germline mutations in the androgen receptor gene and, particularly, in the BRCA2 gene are thought to increase breast cancer risk in male carriers. (bmj.com)
4- 9 Mutations in BRCA2 may account for 75% of families in which there is at least one case of male breast cancer and at least three more cases of female breast cancer. (bmj.com)
10 Most families have a single case of male breast cancer and familial clusters of male breast cancer cases are unusual. (bmj.com)
however, aggregation of male breast cancer cases was observed in only one family from north eastern Poland. (bmj.com)
11, 12 Here, we report a novel BRCA2 mutation in a Polish family with two male breast cancer cases in a father and son and a first case of BRCA2 mutation with loss of heterozygosity in a patient with lung hamartoma. (bmj.com)
Genomic DNA was isolated from peripheral blood lymphocytes of the proband (male breast cancer patient) and seven additional family members using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA). (bmj.com)
It includes two cases of male breast cancer, one case of female genital tract cancer, and one case of hamartoma chondromyxoides. (bmj.com)
The proband, III.1, developed breast cancer at the age of 61. (bmj.com)
The proband's father (patient II.3) died at the age of 74 from breast cancer, two years after diagnosis. (bmj.com)
Male breast cancer and hamartoma family. (bmj.com)
To evaluate the involvement of the BRCA2 6621del4 mutation in the male breast cancer and hamartoma progression, we mapped loss of heterozygosity at the BRCA2 locus in tumour samples. (bmj.com)
What is lobular breast cancer, and how does it develop differently? (patientpower.info)
Tune in to hear patient advocate Diane Mapes shares her diagnosis story of a breast cancer type that's difficult to detect. (patientpower.info)
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. (elsevier.com)
Particularities of Primary Breast Cancer in Men. (omicsonline.org)
Breast cancer in men is rare (1% of all breast cancers) and shows some particularities. (omicsonline.org)
Patients included in the study were diagnosed with breast cancer after pathological examination. (omicsonline.org)
The mean age of men with breast cancer was 67 years, ten years older than women with same disease. (omicsonline.org)
In three cases the breast cancer was the 2nd or 3rd cancer after skin cancer after cancer urothelium and sarcoma soft tissue and in one case with colon cancer, 4 years after breast cancer surgery, with chemotherapy and radiotherapy (Lynch syndrome). (omicsonline.org)
Men have a particular form of breast cancer. (omicsonline.org)
Unlike women, this cancer is found in men at an older age, with a higher rate of lymphatic invasion and hormone receptor positivity. (omicsonline.org)
In 2016, breast cancer was the second most commonly diagnosed cancer in Australia and the most commonly diagnosed cancer in females. (canceraustralia.gov.au)
In 2016, there were 17,492 new cases of breast cancer diagnosed in Australia (138 males and 17,354 females). (canceraustralia.gov.au)
In 2020, it is estimated that 19,974 new cases of breast cancer will be diagnosed in Australia (167 males and 19,807 females). (canceraustralia.gov.au)
The incidence rate for breast cancer is expected to increase with age for both males and females, peaking at age group 70-74 for females. (canceraustralia.gov.au)
The number of new cases of breast cancer diagnosed increased from 5,374 (61 males and 5,313 females) in 1982 to 17,492 in 2016. (canceraustralia.gov.au)
In 2018, breast cancer was the fifth leading cause of cancer death in Australia and also the second most common cause of death from cancer among females. (canceraustralia.gov.au)
In 2018, there were 3,034 deaths from breast cancer in Australia (35 males and 2,999 females). (canceraustralia.gov.au)
The mortality rate for breast cancer is expected to increase with age for females, and be higher among males aged 70 years or over. (canceraustralia.gov.au)
The number of deaths from breast cancer increased from 2,004 (17 males and 1,987 females) in 1982 to 3,034 in 2018. (canceraustralia.gov.au)
Dr. Barry starts out by posing the question "Should a 65-year-old man with no risk factors for prostate cancer except his age and with a normal digital rectal examination undergo a PSA prostate-specific- antigen test? (esro.info)
The mortality from female breast cancer (SMR 1.06), leukaemia and brain cancer was similar to that of the general population. (cdc.gov)

A urogenital neoplasm is a tumor of the urogenital system. (icd.codes)
The primary tumor begins in the breast itself, but once it becomes invasive, it may progress beyond the breast to the regional lymph nodes or travel (metastasize) to other organ systems in the body and become systemic in nature. (thefreedictionary.com)
Classically, the primary tumor begins in the breast and the first place to which it is likely to spread is the regional lymph nodes. (thefreedictionary.com)
Breast metastasis from an extramammary primary tumor is rare, especially in men. (oatext.com)

Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.A small percentage of all breast cancers cluster in families. (icdlist.com)
Hereditary breast cancers tend to develop earlier in life than noninherited (sporadic) cases, and new (primary) tumors are more likely to develop in both breasts. (icdlist.com)
Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial. (bioportfolio.com)
Most cancers of this type are located in the breast. (bioportfolio.com)
There is a small amount of breast tissue, consisting mainly of ducts, in the male chest, and about 1% of breast cancers occur in men. (giantmicrobes.com)
A high cumulative exposure to female sex hormones (estrogen and progesterone) appears to increase the risk of some breast cancers. (thefreedictionary.com)
Like all cancers, breast cancers result from changes in the structure or function of genes that are key to the regulation of cellular growth, differentiation, or repair. (thefreedictionary.com)
About 85% of all male breast cancers are estrogen receptor-positive, and 70% are progesterone receptor-positive. (wikipedia.org)
Lung, colorectal and breast cancers are responsible for the highest number of DALYs in Spain. (biomedcentral.com)
Between 2008 to 2015 in our clinic were treated 319 breast cancers, of which only 11 men, so 3.4%, higher rate to literature data. (omicsonline.org)
The mortality from radiation-related cancers was also reduced in male cockpit crew (SMR 0.73), but not in female or male cabin crews (SMR 1.01 and 1.00, respectively). (cdc.gov)

The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). (nih.gov)
Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? (medscape.com)

Prognosis: Metastatic breast cancerisn't the same for everyone who has it. (answers.com)

Incidence rates of metastasis to the breast as high as 6.6% have been reported when hematologic malignancies are included[ 5 ]. (pubmedcentralcanada.ca)
We report a case of 63-year-old male patient with breast metastasis from lung adenocarcinoma. (oatext.com)
A nodular lesion approximately 1 cm with low increased metabolic uptake (SUVmax:1.74) in left breast was found in positron emission tomography (PET/CT) in addition to mass in the left lung with multiple bone and mediastinal lymph node metastasis. (oatext.com)
Herein, we want to emphasize breast metastasis in male patients with lung adenocarcinoma should be considered although low increased metabolic uptake levels. (oatext.com)
Because of large fibrous tissue areas and poor blood supplying, breast is not suitable for metastasis. (oatext.com)
In this report a case of male patient with lung adenocarcinoma metastasis to the ipsilateral breast was described. (oatext.com)

rare: ovarian neoplasms, congenital malformations. (clinicaladvisor.com)

The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. (nih.gov)
Other less common symptoms include nipple discharge, nipple retraction, swelling of the breast, or a skin lesion such as an ulcer. (wikipedia.org)
Lesions are less contained in males as they do not have to travel far to infiltrate skin, nipple, or muscle tissue. (wikipedia.org)
I noticed a lump in my left breast tissue near my nipple, and I just was so afraid of dealing with it. (patientpower.info)

[ 1 , 2 ] IDP (L/C ST) stands in contrast to IDP small/peripheral subtype (S/P ST), which originates at the terminal duct lobular unit (TDLU) and is usually located peripherally in the breast, is not grossly apparent, and generally occurs in multiples. (medscape.com)

For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. (icd10data.com)
To perform a central pathological review of the corresponding large series of male BC tumors to determine their biologic characteristics and identify relevant prognostic and predictive markers. (clinicaltrials.gov)
The most frequent tumors were breast, gynecological, and hematological growths. (isciii.es)
Background: The present study was undertaken for quantitation of androgen (AR) and vitamin D (VDR) receptor expression in human male and female breast tumors by flow cytometry. (uwi.edu)
Results: Six of 23 female breast tumors had aneuploid DNA content. (uwi.edu)
Eight of 33 male breast tumors had aneuploid DNA content. (uwi.edu)
Twenty-three of 33 male breast tumors were AR positive by flow analysis compared with six that were AR positive by IHC. (uwi.edu)
Six AR-positive (IHC) male tumors were also AR positive by flow analysis. (uwi.edu)
Methods: We performed a retrospective study analyzing patients admitted and treated in First Surgical Clinic, Emergency Hospital "St. Spiridon" Iasi from 1 January 2008 to 31 December 2015 with malignant breast tumors. (omicsonline.org)

A man with a mutation is just as likely to pass this gene to his children as a woman with a mutation. (ndsu.edu)

An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase. (drugbank.ca)

An ultrasound examination showed papillary neoplasms arising from the posterior-lateral left wall of the bladder. (biomedcentral.com)
LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. (medscape.com)

It includes a comprehensive classification of benign and malignant neoplasms. (who.int)

These occur infrequently in males in developed countries, the incidence being about 1% of that in females. (ctdbase.org)
Although PSA expression appeared to correlate with hormone receptor expression, the incidence of PSA expression in our population was too low to draw significant conclusions about an association between PSA expression and hormone receptor status in breast lesions. (pubmedcentralcanada.ca)
In 2016, the age-standardised incidence rate was 65 cases per 100,000 persons (1.0 for males and 126 for females). (canceraustralia.gov.au)
In 2020, it is estimated that the age-standardised incidence rate will increase to 69 cases per 100,000 persons (1.1 for males and 133 for females). (canceraustralia.gov.au)
Over the same period, the age-standardised incidence rate increased from 44 cases per 100,000 persons (1.2 for males and 81 for females) in 1982 to 65 cases per 100,000 in 2016. (canceraustralia.gov.au)

Schnitt S, Collins L. Biopsy Interpretation of the Breast: Biopsy Interpretation Series. (medscape.com)
Papillary lesions of the breast: outcomes of 156 patients managed without excisional biopsy. (medscape.com)
Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. (medscape.com)
Ivan D, Selinko V, Sahin AA, Sneige N, Middleton LP. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. (medscape.com)
Breast papillomas in the era of percutaneous needle biopsy. (medscape.com)
Wang H, Tsang P, D'Cruz C, Clarke K. Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population. (medscape.com)
Not all palpable lesions in the male breast are cancerous, for instance a biopsy may reveal a benign fibroadenoma. (wikipedia.org)

Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ). (icd10data.com)
Excised fresh breast tissue for evaluation and/or treatment of a variety of breast lesions were sampled by FNA technique and placed into PreservCyt. (nih.gov)
In conclusion, FNA of breast tissue placed in PreservCyt is a potentially acceptable method of sample handling for evaluation by the SELDI-TOF methodology for establishment of reproducible protein patterns. (nih.gov)
Fortunately, the majority of breast lumps are non-malignant cysts or fibrous tissue. (giantmicrobes.com)
Groups of glands in normal breast tissue are called lobules. (thefreedictionary.com)

paciente masculino de 53 años de edad, con diagnóstico de cáncer de mama derecha, tipo adenocarcinoma canalicular infiltrante, estadio clínico IIB, con antecedentes de cáncer de mama en 2 familiares directos, mutaciones del gen BRCA1 y positivo tanto a receptores hormonales como para el gen Her2/Neu. (nih.gov)
In familial cases, male BRCA2 carriers are at higher risk, rather than BRCA1 carriers. (wikipedia.org)

The generally accepted definition of MPC was introduced by Worren and Gates, who stated that each neoplasm must represent a distinct malignancy, and that a metastatic origin must be excluded [ 6 ]. (biomedcentral.com)
Aetna considers computer-aided detection of malignancy with MRI of the breast experimental and investigational because its clinical value has not been established. (aetna.com)

Male Breast Neoplasms anonymous support group with information on diagnosis, treatment, symptoms, along with personal stories and experiences with Male Breast Neoplasms. (experienceproject.com)
Jalyn (dutasteride and tamsulosin hydrochloride) is a combination of a benign prostatic hypertrophy agent and an alpha-blocker used in men to treat the symptoms of an enlarged prostate ( benign prostatic hyperplasia - BPH ). (rxlist.com)
Dr. Ruben Mesa walks us through some of the demographics for myelofibrosis neoplasms while addressing various symptoms and stages of the disease. (patientpower.info)

All these definitions are based on the time that the neoplasms are discovered rather than the onset of disease. (biomedcentral.com)
To create a database of patient characteristics, disease features, treatments received, and clinical outcomes of a large series of men diagnosed with BC from 1990 to 2010 in centers in Europe and USA. (clinicaltrials.gov)
The increase in survival in many malignant neoplasms means that, in addition to mortality, it is increasingly necessary to take into account the non-mortal consequences of disease (disability due to the disease itself or to treatment, and the worsening of the patient's quality of life). (biomedcentral.com)
Accordingly, the aim of this study was to estimate and analyse the burden of disease due to malignant neoplasms in Spain in 2000. (biomedcentral.com)
Ischaemic heart disease remains the leading cause of death for men, but has been overtaken as the leading cause of death for women by Dementia & Alzheimer's disease. (abs.gov.au)
For the potential treatment of menstrual-cycle related mastalgia, fibrocystic breast disease, breast disease, gynecomastia and Keloid scarring. (drugbank.ca)

Documentation requirements for neoplasms require specificity in both the site and laterality components. (aapc.com)

estudio prospectivo, observacional y de cohortes que incluye a pacientes oncológicos atendidos por primera vez en el Instituto Nacional de Cancerología durante el periodo de septiembre 2016 a 2017. (isciii.es)
In 2017-18, women (78.0%) were more likely then men (75.9%) to have one or more reported long-term health conditions. (abs.gov.au)

Dr. Ruben Mesa describes the spectrum of possible risks for patients with myeloproliferative neoplasms, particularly polycythemia vera (PV) and essential thrombocythemia (ET). (patientpower.info)

C50.429 is applicable to male patients. (icd10data.com)
Code is only used for male patients. (icd.codes)
Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010. (clinicaltrials.gov)
Metastatic malignancies involving the breast are associated with a poor prognosis, with the majority of patients dying within one year of diagnosis[ 7 - 9 ]. (pubmedcentralcanada.ca)
It is also considerably rarer for male patients. (oatext.com)

Malignant breast neoplasms occur more frequently in females than in males. (nih.gov)
Monitor signs of virilization (females) and development of priapism (males). (mims.com)
Extramammary malignancies metastatic to the breast reportedly represent 0.46 - 5% of all malignant breast fine needle aspiration biopsies in females and males[ 4 ]. (pubmedcentralcanada.ca)
The diagnosis is made later in males-at age 67 on average-than in females with their average at 63. (wikipedia.org)
Life expectancy at birth is greater for Australian females than males, however male life expectancy is improving at a faster rate than that of females. (abs.gov.au)
In 2016-18, life expectancy at birth for females was 4.2 years more than males: 84.9 years for females and 80.7 years for males. (abs.gov.au)
Around 40 years ago (1976), life expectancy for females was 76.4 years compared with 69.4 years for males: a gap of 7.0 years. (abs.gov.au)
In 2015-17, life expectancy at birth for Aboriginal and Torres Strait Islander peoples was higher for females (75.6 years) than males (71.6 years). (abs.gov.au)
It has increased slightly more for males than females since 2005-07: 73.1 years for females and 67.5 years for males. (abs.gov.au)
Overall, there is a ratio of 96.95 males per 100 females. (paho.org)
In 2020, it is estimated that there will be 3,031 deaths (33 males and 2,997 females). (canceraustralia.gov.au)
In 2018, the age-standardised mortality rate was 10 deaths per 100,000 persons (0.3 for males and 19 for females). (canceraustralia.gov.au)
In 2020, it is estimated that the age-standardised mortality rate will be 9.7 deaths per 100,000 persons (0.2 for males and 18 for females). (canceraustralia.gov.au)
Over the same period, the age-standardised mortality rate decreased from 17 deaths per 100,000 persons (0.4 for males and 30 for females) in 1982 to 10 deaths per 100,000 in 2018. (canceraustralia.gov.au)

In this episode, Jean Gariépy and Nicholas Fischer discuss their work, which reveals that the level of residual transcriptional activity of mutant p53 associates with improved survival in males with glioma and gastric adenocarcinoma. (jci.org)
Together, these results support p53 transcriptional activity as a prognostic factor for men with glioma and gastric adenocarcinoma. (jci.org)
The retention of mutant p53 transcriptional activity prognosticates superior survival for men with glioma and gastric adenocarcinoma harboring sporadic TP53 mutations. (jci.org)

An anabolic steroid that has been used in the treatment of male HYPOGONADISM, delayed puberty in males, and in the treatment of breast neoplasms in women. (bioportfolio.com)
A synthetic androgenic anabolic steroid that used in the treatment of hypogonadism and delayed puberty in males, as well as breast neoplasms in women. (drugbank.ca)

These days planning for the future, even with an MPN (myeloproliferative neoplasm) diagnosis, is commonplace. (patientpower.info)

An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. (medscape.com)

In the breast, intraductal papilloma (IDP) is a benign lesion that consists of branching fibrovascular cores with overlying layers of epithelial and myoepithelial cells. (medscape.com)
By the time one can feel a lump in the breast it is often 0.4 inches, or one centimeter, in size and contains roughly a million cells. (thefreedictionary.com)

The prospective 'screening with tomosynthesis or standard mammography' (STORM) trial recruited women participating in biennial breast screening in Italy (2011-2012), and compared sequential screen-rea. (bioportfolio.com)
Multiple Angulated Mammography Reconstructions in Digital Breast Tomosynthesis for the Diagnosis of Microcalcifications - Added Value to Standard Stack Reconstructions and Synthesized Mammography. (bioportfolio.com)
Screening Mammography Findings From One Standard Projection Only in the Era of Full-Field Digital Mammography and Digital Breast Tomosynthesis. (bioportfolio.com)
The purpose of this article is to compare outcomes of findings seen on one view only from screening full-field digital mammography (FFDM) and FFDM plus digital breast tomosynthesis (DBT). (bioportfolio.com)
If an indeterminate breast mass is identified, the initial recommended imaging study is ultrasound in men younger than 25 years and, in men 25 years of age and older, mammography or digital breast tomosynthesis. (medscape.com)
Bilateral mammography should always be obtained to help in the evaluation of the baseline breast architecture. (medscape.com)

The two parts of this study will provide important information regarding male BC biology and clinical evolution. (clinicaltrials.gov)
In men with clinical findings consistent with gynecomastia or pseudogynecomastia, no imaging is routinely recommended. (medscape.com)
The clinical examination is key in the evaluation of a palpable mass in a male. (medscape.com)

Anatomy9

Organisms1

Diseases104

Chemicals and Drugs28

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Psychiatry and Psychology2

Phenomena and Processes21

Disciplines and Occupations1

Technology, Industry, Agriculture1

Information Science3

Named Groups1

Health Care22

Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. (1/361)

Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. (2/361)

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. (3/361)

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. (4/361)

Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (5/361)

A polymorphism in the CYP17 gene is associated with male breast cancer. (6/361)

A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. (7/361)

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer. (8/361)

Breast Neoplasms

Inflammatory Breast Neoplasms

Triple Negative Breast Neoplasms

Breast

Breast Neoplasms, Male

Carcinoma, Ductal, Breast

Breast Diseases

Breast Feeding

Neoplasms

Pancreatic Neoplasms

Receptors, Estrogen

Mammography

Neoplasms, Cystic, Mucinous, and Serous

Cell Line, Tumor

Fibrocystic Breast Disease

Tumor Markers, Biological

Neoplasm Invasiveness

Immunohistochemistry

Neoplasms, Multiple Primary

Receptor, erbB-2

Neoplasm Staging

Breast Implants

Receptors, Progesterone

Gene Expression Regulation, Neoplastic

Neoplasms, Second Primary

Breast Self-Examination

Neoplasm Proteins

Neoplasm Metastasis

Skin Neoplasms

Prognosis

Tamoxifen

DNA, Neoplasm

Carcinoma, Intraductal, Noninfiltrating

Ovarian Neoplasms

Carcinoma

Mastectomy

Adenocarcinoma, Mucinous

Lung Neoplasms

Kidney Neoplasms

Carcinoma, Lobular

Risk Factors

Neoplasm Recurrence, Local

Bone Neoplasms

Lymphatic Metastasis

Ultrasonography, Mammary

Thyroid Neoplasms

Case-Control Studies

Genes, BRCA1

Antineoplastic Agents, Hormonal

Tumor Cells, Cultured

Myeloproliferative Disorders

Mammary Neoplasms, Experimental

Antineoplastic Agents

Liver Neoplasms

Neoplasms, Radiation-Induced

Antigens, Neoplasm

Retrospective Studies

Postmenopause

Fibroadenoma

Parotid Neoplasms

Chemotherapy, Adjuvant

Mastectomy, Segmental

Milk, Human

Cystadenoma

Mammaplasty

Neoplasms, Connective and Soft Tissue

Neoplasms, Plasma Cell

Breast Cyst

Appendiceal Neoplasms

Carcinoma in Situ

Neoplasms, Experimental

Nipples

Treatment Outcome

Estrogens

Biopsy, Needle

Cell Proliferation

Estrogen Receptor alpha

Carcinoma, Papillary

Gastrointestinal Neoplasms

Follow-Up Studies